Drug profile · INN
floxuridine
FLOXURIDINE
floxuridine (FLOXURIDINE) is a thymidylate synthase inhibitor. Associated with Regeneron Ireland Designated Activity Company (DAC). Route of administration: injection. Current US regulatory status: approved.
Drug details — floxuridine
- US status
- approved
- Class
- —
- Route
- INJECTION
- Patents
- 0
- Programs
- 2
- Data quality
- 0.89
Quick answer
floxuridine (FLOXURIDINE) is a thymidylate synthase inhibitor. Associated with Regeneron Ireland Designated Activity Company (DAC). Route of administration: injection. Current US regulatory status: approved.
Key facts
Mechanism of action
Thymidylate synthase inhibitor
Primary target: Thymidylate synthase
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is floxuridine?
floxuridine (FLOXURIDINE) is a thymidylate synthase inhibitor. Associated with Regeneron Ireland Designated Activity Company (DAC). Route of administration: injection. Current US regulatory status: approved.
What is the brand name for floxuridine?
FLOXURIDINE is a marketed brand name for floxuridine. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of floxuridine?
floxuridine has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.